Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
180 Life Sciences Corp. (ATNF)
:ATNF
Holding ATNF?
Track your performance easily
ATNF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.16 - $17.75
Previous Close$1.6
Volume190.96K
Average Volume (3M)783.90K
Market Cap
$5.02M
Enterprise ValueN/A
Total Cash (Recent Filing)$83.40K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.47
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.81
Shares Outstanding3,176,999
10 Day Avg. Volume314,317
30 Day Avg. Volume783,905
Standard Deviation0.98
R-Squared0.03
Alpha0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-3.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
180 Life Sciences News
PremiumCompany Announcements
180 Life Sciences Announces Key Proposals and Director Elections
PremiumCompany Announcements
180 Life Sciences CFO Omar Jimenez Resigns
PremiumCompany Announcements
180 Life Sciences Expands Board with Stephen Shoemaker
PremiumCompany Announcements
180 Life Sciences Expands into Online Gaming SectorOwnership Overview
―
Insiders
0.23% Mutual Funds
0.44% Other Institutional Investors
99.24% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ATNF FAQ
What was 180 Life Sciences Corp.’s price range in the past 12 months?
180 Life Sciences Corp. lowest stock price was $1.16 and its highest was $17.75 in the past 12 months.
What is 180 Life Sciences Corp.’s market cap?
180 Life Sciences Corp.’s market cap is $5.02M.
When is 180 Life Sciences Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were 180 Life Sciences Corp.’s earnings last quarter?
Currently, no data Available
Is 180 Life Sciences Corp. overvalued?
According to Wall Street analysts 180 Life Sciences Corp.’s price is currently Overvalued.
Does 180 Life Sciences Corp. pay dividends?
180 Life Sciences Corp. does not currently pay dividends.
What is 180 Life Sciences Corp.’s EPS estimate?
180 Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does 180 Life Sciences Corp. have?
180 Life Sciences Corp. has 3,176,999 shares outstanding.
What happened to 180 Life Sciences Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of 180 Life Sciences Corp.?
Currently, no hedge funds are holding shares in ATNF
---
Company Description
180 Life Sciences Corp.
KBL Merger Corp. IV is a blank check company, which focuses on acquiring an operating company in the healthcare and related wellness industry. The company was founded on September 7, 2016 and is headquartered in Newark, DE.
---
Technical Analysis
Anixa Biosciences
―
Eloxx Pharmaceuticals
―
Solid Biosciences
―
BioMarin Pharmaceutical
―
Crispr Therapeutics AG
―
---